L3VLUP
ProSign in

XRAY in the 13F filings

Dentsply Sirona Inc · CUSIP 24906P109

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
14 Aug 2024
latest of these filings; the earliest 26 Jul 2024
Managers listing it
9
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 8 listed it in both
Shares listed
31,354,583
combined, among listed positions
Reported value
$781m
combined, at the quarter end

Among the 94 comparable managers: 7 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing XRAY in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

9 of 9 holders

ActionFiling
First Eagle Investment Management LLC13,069,900$326m0.73%Added+3,283,96512 Aug 2024 (the filing on sec.gov)
Janus Henderson Group Ltd7,562,367$188m0.10%Added+29,90314 Aug 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc7,006,827$175munder 0.1%Added+740,04614 Aug 2024 (the filing on sec.gov)
Artisan Partners LP1,929,494$48m0.07%Trimmed-22,63412 Aug 2024 (the filing on sec.gov)
Arrowstreet Capital LP1,151,926$29munder 0.1%Trimmed-86,83614 Aug 2024 (the filing on sec.gov)
Bridgewater Associates LP302,021$7.5munder 0.1%Added+38,08214 Aug 2024 (the filing on sec.gov)
Quantbot Technologies LP154,591$3.9m0.19%Added+77,3419 Aug 2024 (the filing on sec.gov)
ARK Investment Management LLC135,949$3.4munder 0.1%Added+20526 Jul 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP41,508$1.0munder 0.1%Newnew14 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
8 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

010203020162017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
XRAY by quarter
QuarterHoldersReported valueBuyersSellers
Q1 201617$3.1bnn.a.n.a.
Q2 201618$3.0bnn.a.n.a.
Q3 201615$2.8bnn.a.n.a.
Q4 201614$2.7bnn.a.n.a.
Q1 201719$2.7bnn.a.n.a.
Q2 201713$2.6bnn.a.n.a.
Q3 201713$2.6bnn.a.n.a.
Q4 201712$2.6bnn.a.n.a.
Q1 201817$1.4bnn.a.n.a.
Q2 201812$933mn.a.n.a.
Q3 201818$1.6bnn.a.n.a.
Q4 201813$1.6bnn.a.n.a.
Q1 201913$1.8bnn.a.n.a.
Q2 201914$2.1bnn.a.n.a.
Q3 201916$1.9bnn.a.n.a.
Q4 201916$2.0bnn.a.n.a.
Q1 202016$1.5bnn.a.n.a.
Q2 202016$2.1bnn.a.n.a.
Q3 202014$2.3bnn.a.n.a.
Q4 202011$2.7bnn.a.n.a.
Q1 202116$3.7bnn.a.n.a.
Q2 202123$3.8bnn.a.n.a.
Q3 202118$3.3bnn.a.n.a.
Q4 202113$2.8bnn.a.n.a.
Q1 202216$2.8bnn.a.n.a.
Q2 202218$2.0bnn.a.n.a.
Q3 202217$1.5bnn.a.n.a.
Q4 202214$1.6bnn.a.n.a.
Q1 202311$2.2bnn.a.n.a.
Q2 202310$1.9bnn.a.n.a.
Q3 202315$1.7bnn.a.n.a.
Q4 202313$1.7bn97
Q1 202412$1.1bn85
Q2 20249$781m73
Q3 20248$941m62
Q4 20249$648m82
Q1 20259$586m82
Q2 20258$639m36
Q3 20256$369m42
Q4 20255$199m239
Q1 20267$273m1717
Q2 20265$61m1019

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

XRAY and LLY →XRAY and JNJ →XRAY and VRTX →Choose a stock to compare with XRAY →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own XRAY, latest filings →Back to the 13F Explorer →